<List><item><source>MED</source><extId>28707500</extId><pmcid>PMC5676497</pmcid><annotations><annotation><prefix>treatment of NSCLC (</prefix><exact>NCT03014648</exact><postfix>, NCT02848651, and N</postfix><tags><tag><name>NCT03014648</name><uri>http://identifiers.org/clinicaltrials/NCT03014648</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-f2c89359e9612acd6b30f534f2d431b2</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>NSCLC (NCT03014648, </prefix><exact>NCT02848651</exact><postfix>, and NCT02927301), </postfix><tags><tag><name>NCT02848651</name><uri>http://identifiers.org/clinicaltrials/NCT02848651</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-36dd37ea6a5d88f17eb6d809d1365dbc</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>8, NCT02848651, and </prefix><exact>NCT02927301</exact><postfix>), advanced or metas</postfix><tags><tag><name>NCT02927301</name><uri>http://identifiers.org/clinicaltrials/NCT02927301</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-b42ff7a827288d4f5f29019f8cffdbae</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ial bladder cancer (</prefix><exact>NCT02951767</exact><postfix>, NCT02108652), gyne</postfix><tags><tag><name>NCT02951767</name><uri>http://identifiers.org/clinicaltrials/NCT02951767</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-8f93908272cdc5bde84f568e1a052a1a</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ancer (NCT02951767, </prefix><exact>NCT02108652</exact><postfix>), gynecological can</postfix><tags><tag><name>NCT02108652</name><uri>http://identifiers.org/clinicaltrials/NCT02108652</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-00528dc73abc81b6b166d9c1acacc8d3</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>ecological cancers (</prefix><exact>NCT03073525</exact><postfix>), Hodgkin lymphoma </postfix><tags><tag><name>NCT03073525</name><uri>http://identifiers.org/clinicaltrials/NCT03073525</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-c546d7d8cccfe82b4f723ba7f1384382</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>, Hodgkin lymphoma (</prefix><exact>NCT03120676</exact><postfix>), colorectal cancer</postfix><tags><tag><name>NCT03120676</name><uri>http://identifiers.org/clinicaltrials/NCT03120676</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-6470b637f1d3741cd1d7b54c4fe30d26</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix> colorectal cancer (</prefix><exact>NCT02982694</exact><postfix>), TNBC (NCT03125902</postfix><tags><tag><name>NCT02982694</name><uri>http://identifiers.org/clinicaltrials/NCT02982694</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-450436f52b3ffc120cb6abc55607fbb5</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>NCT02982694), TNBC (</prefix><exact>NCT03125902</exact><postfix>), prostate cancer (</postfix><tags><tag><name>NCT03125902</name><uri>http://identifiers.org/clinicaltrials/NCT03125902</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-6393996749dd6f000f7f1fff4808b0ec</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>), prostate cancer (</prefix><exact>NCT02814669</exact><postfix>), nonclear cell kid</postfix><tags><tag><name>NCT02814669</name><uri>http://identifiers.org/clinicaltrials/NCT02814669</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-1b06da42768578a0b0c5ba97506cbb4c</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>cell kidney cancer (</prefix><exact>NCT02724878</exact><postfix>), and RCC (NCT03024</postfix><tags><tag><name>NCT02724878</name><uri>http://identifiers.org/clinicaltrials/NCT02724878</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-9c39cc49f1773874ca6f21f333b4b42d</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation><annotation><prefix>idney cancer (NCT02724878), and RCC (</prefix><exact>NCT03024996</exact><postfix>). </postfix><tags><tag><name>NCT03024996</name><uri>http://identifiers.org/clinicaltrials/NCT03024996</uri></tag></tags><id>http://europepmc.org/articles/PMC5676497#europepmc-4368e14d18cd7825571bcfaa9f12eed2</id><type>Accession Numbers</type><section>Article (http://semanticscience.org/resource/SIO_001029)</section><provider>Europe PMC</provider><subType>NCT</subType></annotation></annotations></item></List>